SVLSF Iv, LLC, 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), sold 6,826 shares at $20.41 ($139K) on 2019-01-07, disclosed to the SEC on 2019-01-07.
Open-market sale of $139k KALV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 47 | $940 | 0.7% |
| 2 | $20.01 | 1,653 | $33K | 23.9% |
| 3 | $20.41 | 72 | $1K | 1.1% |
| 4 | $20.41 | 2,527 | $52K | 37.2% |
| 5 | $20.41 | 2,527 | $52K | 37.2% |
| Total | $20.31 avg | 6,826 |
| $139K |
| 100% |
| Filing → |
| ENTL | BUY | 2015-02-04 | $5.4M | — | Filing → |
| OCUL | BUY | 2014-07-31 | $6.2M | — | Filing → |
| OPHT | SELL | 2014-06-02 | $25.5M | — | Filing → |